Neurology focus Ever Pharma specializes in neurology and related injectables, presenting opportunities to cross-sell or co-develop advanced delivery systems, and to expand D-mine pump therapy integration with partner clinics and telemedicine services in neurology networks.

Global reach With presence in over 70 countries and a distribution network including strategic partners, there are sales expansion opportunities through new regional partnerships, contract manufacturing collaborations, and channel optimization in high-potential markets.

Specialty injectables The company’s EU GMP certified facilities handle high potency and controlled substances as well as complex injectable formats, suggesting potential for GMP-compliant contract manufacturing, fill-finish partnerships, and co-development of specialized injectable therapies.

Parkinsons portfolio D-mine Pump and related Dacepton products indicate a patient-centric Parkinson’s disease package; opportunities exist to broaden therapy adoption through payer engagement, clinical partnerships, and expansion to adjacent neurology indications requiring subcutaneous infusion delivery.

Digital/tech enablement Existing tech stack including mobile app, digital tools, and cloud collaboration opens doors for digital health collaborations, remote monitoring solutions, and data-driven support services for healthcare professionals and patients to drive adoption and adherence.